Drug – bio-affecting and body treating compositions – Antigen – epitope – or other immunospecific immunoeffector – Parasitic organism or component thereof or substance...
Patent
1981-01-29
1982-06-08
Schwartz, Richard A.
Drug, bio-affecting and body treating compositions
Antigen, epitope, or other immunospecific immunoeffector
Parasitic organism or component thereof or substance...
548301, 548315, 548321, 548337, 548342, A61K 31415, C07D23364, C07D23368
Patent
active
043339468
ABSTRACT:
The compounds are novel N-substituted-N'-heterocyclic alkylthioureas, guanidines and 1-nitro-2,2-diaminoethylene compounds which are histamine H.sub.2 -antagonists.
REFERENCES:
patent: 3808336 (1974-04-01), Durant et al.
patent: 3868457 (1975-02-01), Black et al.
patent: 3950333 (1976-04-01), Durant et al.
patent: 3950353 (1976-04-01), Durant et al.
patent: 3953460 (1976-04-01), Durant et al.
patent: 3968216 (1976-07-01), Black et al.
patent: 3968227 (1976-07-01), Durant et al.
patent: 3979398 (1976-09-01), White
patent: 4000296 (1976-12-01), Durant et al.
patent: 4000302 (1976-12-01), Black et al.
patent: 4034101 (1977-07-01), Durant et al.
patent: 4046907 (1977-09-01), Durant et al.
patent: 4109003 (1978-08-01), Durant et al.
patent: 4124717 (1978-11-01), Durant et al.
patent: 4152443 (1979-05-01), Durant et al.
patent: 4165377 (1979-08-01), Jones et al.
patent: 4165378 (1979-08-01), Gilman et al.
Derwent Abstract 30208S (Belgian 758,146).
Derwent Abstract 00068X (Belgian 830,272).
Durant Graham J.
Ganellin Charon R.
Owen Geoffrey R.
Young Rodney C.
Foggio Richard D.
Keps Joan S.
Lourie Alan D.
Schwartz Richard A.
Smith Kline & French Laboratories Limited
LandOfFree
Blocking histamine H.sub.2 -receptors with imidazolylalkyl guani does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Blocking histamine H.sub.2 -receptors with imidazolylalkyl guani, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Blocking histamine H.sub.2 -receptors with imidazolylalkyl guani will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-552882